Nightingale Health Oyj Future Growth
Future criteria checks 2/6
Nightingale Health Oyj is forecast to grow earnings and revenue by 17.1% and 42.4% per annum respectively. EPS is expected to grow by 17.5% per annum. Return on equity is forecast to be -22.6% in 3 years.
Key information
17.1%
Earnings growth rate
17.5%
EPS growth rate
Healthcare earnings growth | 25.0% |
Revenue growth rate | 42.4% |
Future return on equity | -22.6% |
Analyst coverage | Low |
Last updated | 27 Sep 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 17 | -12 | -14 | -7 | 1 |
6/30/2026 | 11 | -14 | -17 | -10 | 1 |
6/30/2025 | 7 | -17 | -17 | -11 | 1 |
6/30/2024 | 4 | -17 | -13 | -8 | N/A |
3/31/2024 | 4 | -18 | N/A | N/A | N/A |
12/31/2023 | 4 | -18 | -11 | -8 | N/A |
9/30/2023 | 4 | -18 | -12 | -7 | N/A |
6/30/2023 | 4 | -18 | -12 | -7 | N/A |
3/31/2023 | 4 | -18 | -14 | -8 | N/A |
12/31/2022 | 3 | -19 | -16 | -9 | N/A |
9/30/2022 | 3 | -17 | -15 | -8 | N/A |
6/30/2022 | 2 | -16 | -15 | -7 | N/A |
3/31/2022 | 2 | -14 | -12 | -5 | N/A |
12/31/2021 | 3 | -12 | -9 | -3 | N/A |
9/30/2021 | 2 | -11 | -7 | -3 | N/A |
6/30/2021 | 2 | -10 | -5 | -2 | N/A |
3/31/2021 | 2 | -8 | -7 | -3 | N/A |
12/31/2020 | 2 | -5 | -9 | -3 | N/A |
9/30/2020 | 2 | -4 | -10 | -3 | N/A |
6/30/2020 | 2 | -4 | -11 | -3 | N/A |
6/30/2019 | 2 | -4 | -7 | -4 | N/A |
6/30/2018 | 2 | -3 | N/A | N/A | N/A |
6/30/2017 | 2 | -1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HEALTH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HEALTH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HEALTH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HEALTH's revenue (42.4% per year) is forecast to grow faster than the Finnish market (2.6% per year).
High Growth Revenue: HEALTH's revenue (42.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HEALTH is forecast to be unprofitable in 3 years.